Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer
Minna Tanner(Tampere University Hospital), Jorma Isola(Tampere University Hospital)
Cited by 269
Related Papers
Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer
|New England Journal of Medicine|2006|1.4k
Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial
|Journal of Clinical Oncology|2009|459
Trastuzumab-DM1 causes tumour growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cells in vivo
|Breast Cancer Research|2011|232